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Abstract - Andropause, the culminating phase of ageing in males is characterized by the decline of the growth hormone 
(GH)/insulin-like growth factor 1 (IGF-1) axis that is responsible for somatic development. Estrogens on the other hand, 
assume a relevant somatic role, as well as the one in the pituitary. They are particularly interesting because of their thera-
peutic uses in certain common ageing-associated diseases. The aim of the present study was to examine the effects of 
subcutaneous treatment with estradiol, dipropionate on the immunohistomorphometric features of GH cells, in an animal 
model of the andropause. Sixteen-month-old Wistar rats were divided into sham-operated (SO), orchidectomized (Orx) 
and estradiol dipropionate-treated orchidectomized (Orx+Edp) groups. Estradiol dipropionate (0.625 mg/kg/day) was 
administered subcutaneously for three weeks while the SO and Orx groups received the vehicle alone. GH cells were 
identified by the peroxidase-antiperoxidase (PAP) immunohistochemical procedure. In the Orx+Edp group, GH cell vol-
umes as well as the relative volume densities were significantly (p<0.05) decreased, by 27.4% and by 61.1%, respectively, in 
comparison with the same parameters of SO animals. Compared to the Orx animals, the cell volumes and relative volume 
densities of GH cells in Orx+Edp group were also significantly (p<0.05) decreased, by 23.2% and by 64.1%, respectively. It 
can be concluded that chronic estradiol dipropionate application in an animal in the andropause results in the suppression 
of immunohistochemical and morphometric parameters of pituitary GH cells. 
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INTRODUCTION
Ageing in males culminates in the andropause or 
“symptomatic late-onset hypogonadism” (Morales, 
2004), which considers a number of symptoms relat-
ed to the lack of androgens (Vance, 2003). The growth 
hormone (GH)/insulin-like growth factor 1 (IGF-1) 
axis, which is responsible for somatic development, 
is also reduced in advanced age (Thompson et al., 
2003), thus affirming the concept of somatopause 
within andropause. Age-associated pituitary GH cell 
attenuation appears as the result of an imbalance be-
tween the hypothalamic release of somatostatin and 
the growth hormone-releasing hormone (GHRH) 
(Epelbaum, 2008). These physiological changes re-
sult in manifestations such as frailty, increased fat 
mass and cardiovascular risk, reduced muscle mass 
and a generally impaired quality of life (Ceda et al., 
2010; Di Somma et al., 2011).
Estrogens are very important mediators in 
skeletal growth and maturation during develop-
ment in both genders, as well as in later bone mass 
maintenance (Grumbach and Auchus, 1999). It 
was suggested that estrogen deficiency might cause 
osteopenia and osteoporosis even at an earlier age 
452 VERICA MILOŠEVIĆ ET AL.
(Carani et al., 1997). In addition, estrogen induc-
es insulin-mediated pituitary cells proliferation 
(Takahashi et al., 1994). Finally, the application of 
estrogen agonists, besides radio- and chemo-ther-
apy, represents the classical hormonal approach in 
the therapy of prostate cancer that is frequent in 
advanced age (Tamella, 2004). Obviously, the es-
trogens play a relevant somatic role, as well as a 
role in the pituitary. They are especially of interest 
because of their therapeutic use in some common 
ageing diseases.
Considering pituitary GH cells as the opera-
tive component of the GH/IGF1 axis, as well as the 
functional decline of the axis with ageing, the aim of 
this study was to investigate the effects of subcuta-
neous treatment with estradiol dipropionate on the 
immunohistomorphometric features of GH cells in 
an animal model of andropause. Orchidectomy was 
performed to eliminate endogenous testosterone and 
estradiol from the hormonal milieu and their poten-
tial effects on the GH cells.
MATERIALS AND METHODS
Animals and diets
Sixteen-month-old (andropausal) male Wistar rats 
were used. The rats were bred in the Institute for Bio-
logical Research “Siniša Stanković”, Belgrade, Serbia. 
The animals were housed one per cage, exposed to a 
12 h light/dark cycle and kept at 22±2ºC. Two weeks 
before the experiment, the rats were given a soy-free 
diet, prepared in cooperation with the Department 
of Food, School of Veterinary Medicine, Belgrade, 
Serbia, and INSHRA PKB, Belgrade, Serbia, accord-
ing to Picherit et al. (2000), with corn oil as the fat 
source.
The diet contained per 100 g: 20.3 g casein; 65 g 
carbohydrate (45 g cornstarch + 20 g sucrose); 5.2 g 
corn oil; 3.7 g fiber (crystalline cellulose); 1.5 g vita-
min/mineral mix (calcium-phosphate deficient); 1.8 
g calcium-phosphate dibasic; 1 g calcium carbonate; 
1.5 g DL-methionine. Casein and crystalline cellu-
lose were obtained from Alfa Aesar, Johnson Mat-
they Gmbh & Co. KG, Karlsruhe, Germany; carbo-
hydrate, oil, vitamin/mineral mix, calcium carbonate 
and calcium phosphate were from INSHRA PKB, 
Belgrade, Serbia, and DL-methionine was obtained 
from Sigma Chemical Company, St. Louis, MO, 
USA. Food and water were available ad libitum.
Animal treatments
At the age of 15 months, the experimental animals 
were bilaterally orchidectomized (Orx) or sham-
operated (SO) under Ketamine anesthesia (15mg/
kg b.w.; Richter Pharma, Wels, Austria.). The recov-
ery period lasted two weeks after the surgery. The 
orchidectomized rats were then divided into three 
groups of eight animals (n=8) each. The first group 
was subcutaneously treated with estradiol dipropion-
ate (Galenika, Belgrade, Serbia; Orx+Edp) at a dose 
of 0.625 mg/kg b.w., every day except on Sundays, for 
3 weeks. The second (Orx) and third (SO) groups re-
ceived a sterile olive oil (0.5 ml per animal), following 
the same schedule. All the animals were killed by de-
capitation under ether anesthesia (ether narcosis Ph. 
Iug. III., Lek, Ljubljana, Slovenia) 24 h after the last 
injection. The experimental protocols were approved 
by the Animal Care Committee of the Institute for 
Biological Research (Belgrade, Serbia) and were in 
conformity with the recommendation provided in 
the European Convention for the Protection of Ver-
tebrate Animals used for Experimental and Other 
ScientificPurposes (ETS No. 123, Appendix A). 
Light microscopy and immunocytochemistry
The pituitary glands were excised, fixed in Bouins’ 
solution for 48 h and embedded in paraplast. Serial 
5-µm thick tissue sections were deparaffinized in xy-
lol and serial alcohol. GH was localized by the per-
oxidase-antiperoxidase complex (PAP) method of 
Sternberger et al. (1970). The endogenous peroxidase 
activity was blocked by incubation in 9 mmol (0.3%) 
hydrogen peroxide solution in methanol for 15 min 
at ambient temperature. Before the application of the 
specific primary antisera, nonspecific background 
staining was prevented by incubating the sections 
with nonimmune, i.e. normal, porcine serum diluted 
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with phosphate buffered saline (PBS) pH 7.4 for 60 
min. Sections were then overlaid with appropriate di-
lutions of the specific primary antibodies (hGHantis-
era, Dako A/S, Glostrup, Denmark; diluted 1:200 in 
PBS) for 24 h at room temperature. This antibody 
strongly cross-reacts with rat GH (Milošević et al., 
1994). After washing in PBS for 5 min, sections were 
incubated for 60 min with a secondary antibody, 
swine anti-rabbit IgG (DAKO, Glostrup, Denmark; 
diluted 1:100 in PBS); rinsed again in PBS for 5 min 
and then incubated with rabbit PAP complex (DAKO 
A/S, Glostrup, Denmark; diluted 1:100 in PBS), for 
45min. Binding sites were visualized using 0.05% di-
aminobenzidine (DAB; Serva, Heidelberg, Germany) 
and 0.03% hydrogen peroxide in a 0.2M TRIS-HCl 
buffer, pH 7.4. The sections were counterstained with 
hematoxylin and mounted in Canada balsam (Molar 
Chemicals KFT, Budapest, Hungary). For the control 
sections, the primary antibody was omitted and re-
placed by PBS, pH 7.4.
Morphometry
Rat pituitaries were serially cut to 5 µm thick sec-
tions. Two sections from the dorsal, three from the 
middle and two from the ventral part (seven sec-
tions, 20 μm apart in total) of the rat pituitary glands 
were analyzed. The point counting method was used 
at an overall magnification of x1000 (Weibel, 1979). 
The M42 multipurpose test grid, inserted into the 
ocular of a Zeiss light microscope (Jena, Germany), 
was randomly positioned on the pituitary section at 
the beginning of counting. Counting was carried out 
on the following 50 test fields per section. Average 
values were calculated per pituitary i.e. per animal (7 
sections, 350 test fields) and five pituitaries were ana-
lyzed per group. Cell volume (Vc, μm3), volume of 
the nuclei (Vn; μm3) and volume density (percentage 
of immunoreactive cells in μm3, VVC; %) were deter-
mined for GH-immunoreactive cells. 
The following parameters were counted:
Pn – the number of points hitting on nuclei of im-
munohistochemically-labeled cells inside the test 
field;
Ptc – the number of points hitting on the cytoplasm 
of immunohistochemically-labeled cells inside the 
test field.
Nn -  the number of immunohistochemically-labeled 
cell nuclei inside the test field 
The formula used for calculating the nuclear vol-
umes was: 
Vn = VVn/ NV 
The formula used for calculating the cell volume 
was:
Vc = 1/ NV 
VVn is the volume density of GH cell nuclei and NV is 
the numerical density of GH cells. The nuclear vol-
ume density (VVn) provides information about the 
nuclear presence in the estimated cells and is calcu-
lated as follows: 
VVn =ΣPn/ΣPtc
Since rat GH cells are mononuclear, NV corresponds 
to the number of cells per cubic millimeter, accord-
ing to the formula: 
NV = (k/β) (NA3/2 / VVn ½ )
On the basis of earlier karyometric studies (Malen-
dowicz, 1974), the shape coefficient β for pituitary 
cells was estimated to be 1.382, k is a factor related 
to cell distribution according to their size (in the case 
of GH cells its value is 1) and NA is the number of 
cells in the plane of the pituitary tissue section. NA is 
calculated as follows: 
NA = ΣNn/ΣPtc · a ,
where a represents the rhombic area belonging to 
every point of the test system and is calculated using 
the formula: 
a = d2 3 1/2/2  
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where d is the test line length in the test system em-
ployed.
Volume density (VVC) is calculated as the ratio of 
the sum of Pn and Ptc (Pn+Ptc) and the total number 
of points in the test system. Since the test system with 
42 points was used and parameters were calculated 
using 50 test fields, the final formula was:
VVC = (Pn+Ptc)/ 50 · 42
Statistical analyses
Morphometric data obtained for the experimental 
groups were subjected to one-way analyses of vari-
ance (ANOVA). Duncan’s multiple range tests was 
used for post hoc comparisons between groups. A 
confidence level of p<0.05 was considered statisti-
cally significant. The data are presented as means 
± SD. 
RESULTS AND DISCUSSION
Data for the body weight, the absolute and relative 
pituitary weights in the andropausal rats are sum-
marized in Table 1. The body weights in Orx and 
Orx+Edp rats were decreased (p<0.05) by 10% and 
16%, respectively, compared to the SO group. The ab-
solute pituitary weight in the Orx+Edp animals was 
significantly increased (p<0.05) in comparison with 
the SO and Orx animals, by 150% and 156%, respec-
tively. The relative pituitary weight in the Orx+Edp 
group was also significantly increased (p<0.05) by 
254% and 212%, compared to the SO and Orx rats, 
respectively.
Table 1. Body weight, absolute and relative pituitary weights in sham-operated (SO), orchidectomized (Orx) and estradiol dipropionate 
(Orx+Edp) treated orchidectomized andropausal rats.
SO Orx Orx+Edp
Body weight before the surgery (g) 680.0±30.0
Body weight before the treatment (g) 654.0±8.0 639.0±63.0 639.0±63.0
Body weight after the treatment (g) 650.0±29.0 586.0 ±35.0a 548.0±32.0a
Absolute pituitary weight (mg) 17.0±1.7 16.6 ±1.4 42.5±8.0a,b
Relative pituitary weight (mg/%) 2.2±0.1 2.5±0.2a 7.8±0.6a,b
Mean ± SD, n=8/group;  ap<0.05 vs. SO rats, bp<0.05 vs. Orx rats
Fig. 1. Immunohistochemically labeled GH cells (marked with 
arrows) in: A) sham operated (SO) B) orchidectomized (Orx) 
and C) orchidectomized and estradiol dipropionate (Orx+Edp) 
treated andropausal rats (PAP; bar-16 µm).
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The more pronounced decrease in body weight 
was observed after the estradiol dipropionate treat-
ment of orchidectomized animals. This led us to 
conclude that not only testosterone deprivation was 
responsible for the change. Namely, it was observed 
that estradiol induces hypophagia, associated with 
the increased hypothalamic expression of anorexi-
genic neuropeptides (Silva et al., 2010). In middle-
aged female rats, chronic estradiol treatment was 
shown to increase absolute pituitary weight (Kostić 
et al., 2003). In addition, it has been demonstrated 
that estradiol treatment increases the number of 
chromophobes, PRL (Pantić 1980, 1995; Milošević et 
al., 2007) and LH cells (Lovren et al., 1997), which 
supports our results.
Immunohistochemically identified GH cells in 
SO and Orx rat pituitaries were ovoid to pyramidal 
in shape, with a spherical, centrally located nucleus. 
They were usually situated along the blood capillar-
ies (Figs. 1A, 1B). In the Orx+Edp rats, the GH cells 
were smaller, irregularly shaped, with more intensely 
stained secretory granules (Fig. 1C), while the blood 
capillaries were dilated. Similar immunohistochemi-
cal findings were observed in middle-aged female rat 
pituitaries after treatment with estradiol (Milošević et 
al., 2005). 
Morphometric studies revealed a significant de-
crease (p<0.05) in GH cell volumes and in relative 
volume densities (Figs. 2A, 2C) in the Orx+Edp rats, 
by 27.4% and 61.1%, respectively, compared to the 
respective parameters in the SO animals. The cell 
volumes and relative volume densities of GH cells in 
the Orx+Edp group were also significantly decreased 
(p<0.05), by 23.2% and 64.1% respectively, in com-
parison with the Orx animals. The nuclear volumes 
of GH cells were not significantly (p>0.05) changed 
in the Orx+Edp rats compared to both the SO and 
Orx groups (Fig. 2B).
As noted, andropause brings about certain 
changes at the level of GH cells. Estrogens are in-
teresting because of their therapeutic use in some 
common ageing diseases. They generally assume rel-
evant somatic roles. Several authors have reported 
a decrease in the pituitary GH content with ageing 
in rats (Takahashi, 1992; Mobbs, 1996). The GH cell 
hormonal content decrease, observed in middle-
aged rat females, was interpreted to be partly due to 
an increase in somatostatin release from hypothala-
Fig. 2. A) Cell volume (Vc; µm3), B) Nu clear volume (Vn; µm3) 
and C) Relative volume density (Vv; %), expressed as percentages 
of total glandular tissue of immunopositive GH cells. The values 
are the means ± SD, (n=8/group); ap<0.05 vs. SO rats, bp<0.05 vs. 
Orx rats.
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mus (Takahashi et al., 1987). In adult and old rats, it 
was reported that GHRH and GHRH receptor genes 
were insensitive to androgens, so orchidectomy does 
not affect GHRH levels (De Gennaro Collona et al., 
1991; Mayo et al., 2000). On the other hand, an earlier 
study demonstrated that estrogens reduce GHRH as 
well as GH secretion and lower pituitary responsive-
ness to GHRH stimulation (Pantić, 1980). Finally, 
estrogen directly inhibits the activity of the GHRH 
receptor gene promoter (Petersenn et al., 1998).
Based on the results presented here, it can be 
concluded that chronic estradiol dipropionate appli-
cation in an animal model of the andropause results 
in the suppression of immunohistochemical and 
morphometric parameters of pituitary GH cells. 
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